Clearside Biomedical Inc Capital Reinvestment Ratio

Latest as of December 2023: 0.24x

Clearside Biomedical Inc capital reinvestment ratio. Clearside Biomedical Inc (CLSD) has a Capital Reinvestment Ratio of 0.24x as of December 2023, meaning it reinvests 0% of its operating cash flow ($495.00K) in capital expenditures ($120.00K). Check Clearside Biomedical Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.24x

Capex / Operating Cash Flow

Operating Cash Flow

$495.00K

USD

Capital Expenditures

$120.00K

USD

Data as of

Dec 2023

Most recent filing

Clearside Biomedical Inc Capital Reinvestment Ratio by Year (None–None)

Clearside Biomedical Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash flow conversion of Clearside Biomedical Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow